Pharming Group N.V. ADR
(PHAR)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2002 | 12-2001 | 12-2000 | 12-1999 | 12-1998 | |
| Gross Profit | 590 | 490 | 680 | 730 | 2,440 |
| Operating Expenses | 6,000 | 3,950 | 3,690 | 2,770 | 2,650 |
| Operating Income | -6,000 | -3,950 | -3,690 | -2,770 | -2,650 |
| Pre-tax Income | -6,000 | -3,950 | -3,690 | -2,770 | -2,650 |
| Net Income Continuous | -6,000 | -3,950 | -3,690 | -2,770 | -2,650 |
| Net Income | $-6,000 | $-3,950 | $-3,690 | $-2,770 | $-2,650 |
| EBITDA(a) | $-4,350 | $-2,450 | $-2,560 | $-1,650 | $-1,490 |